Drug Shortage Report for LEVOTHYROXINE SODIUM FOR INJECTION
Report ID | 127630 |
Drug Identification Number | 02461722 |
Brand name | LEVOTHYROXINE SODIUM FOR INJECTION |
Common or Proper name | Levothyroxine 500mcg / vial |
Company Name | AVIR PHARMA INC. |
Market Status | MARKETED |
Active Ingredient(s) | LEVOTHYROXINE SODIUM |
Strength(s) | 500MCG |
Dosage form(s) | POWDER FOR SOLUTION |
Route of administration | INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS |
Packaging size | 1 |
ATC code | H03AA |
ATC description | THYROID PREPARATIONS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | 2020-10-30 |
Actual start date | 2020-10-31 |
Estimated end date | 2020-11-13 |
Actual end date | 2020-11-09 |
Shortage status | Resolved |
Updated date | 2020-11-16 |
Company comments | Levothyroxine 200mcg/vial available |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 660 BOULEVARD INDUSTRIEL BLAINVILLE, QUEBEC CANADA J7C 3V4 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v8 | 2020-11-16 | French | Compare |
v7 | 2020-11-16 | English | Compare |
v6 | 2020-11-01 | English | Compare |
v5 | 2020-10-30 | French | Compare |
v4 | 2020-10-30 | English | Compare |
v3 | 2020-10-30 | French | Compare |
v2 | 2020-10-30 | English | Compare |
v1 | 2020-10-30 | English | Compare |
Showing 1 to 8 of 8